Prairie Village, KS – July 28, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced that Raymond (Chip) Richter has joined the company as Vice President of Reimbursement. Richter is a healthcare executive and leader with over two decades of experience in healthcare economics, reimbursement, health policy and government affairs. He will be responsible for leading Artio’s

Read More

Prairie Village, KS – July 12, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced that Emily Holliday has joined the company as Vice President of Human Resources. A seasoned executive with over 20 years of human resources (HR) experience, Holliday will lead HR at Artio and lead the company’s efforts to recruit, develop, and retain top

Read More

Prairie Village, KS – June 23, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the appointment of veteran medical device executive Joseph Ingoglia as Chief Commercial Officer. Ingoglia will be responsible for building Artio’s sales and marketing teams and driving revenue growth from the commercialization of the Company’s broad and deep product pipeline, with an initial

Read More

Funding to launch commercial sales team in US and continue development of best-in-class product pipeline Prairie Village, KS – June 16, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million. Funds will be used

Read More

Read More

Company Prepares for US Commercial Launch Prairie Village, KS – March 22, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced it received US Food and Drug Administration (FDA) clearance for its Solus Gold Embolization Device, a next-generation product for peripheral vascular occlusion. “Current occlusion devices can be difficult to position in challenging anatomy, often require multiple implants, and

Read More

Prairie Village, KS – February 24, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, today announced the hiring of Dan Tamez as Senior Director of Nonclinical and Clinical Research and the engagement of Geoff Tansley, PhD as Senior R&D Consultant. Tamez will lead nonclinical research for Artio’s diverse product portfolio and work as a member of Artio’s clinical research

Read More

Prairie Village, KS – January 26, 2022 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that Megan Giorgini has joined the company as Senior Director of Human Resources. Giorgini, a proven leader with nearly 20 years of human resources experience, will be responsible for leading Artio’s HR organization and managing recruitment efforts. “Artio has seen rapid growth

Read More

Presents update on novel neurovascular medical device at B.R.A.I.N. Conference  Prairie Village, KS – December 14, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that distinguished neurovascular and peripheral vascular interventional radiologist, Blaise W. Baxter, MD, FRCPC, FSNIC, has joined the company’s leadership team as Vice President of Neurovascular and Peripheral Vascular Interventions. In his

Read More

Company plans construction of a new commercial manufacturing facility Prairie Village, KS – December 8, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that the City Council of Olathe, KS has approved a development agreement granting land to the Company for commercial manufacturing operations. Artio plans to build two commercial manufacturing buildings on an 18-acre

Read More

Read More

Prairie Village, KS – November 30, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that full results from its first-in-human (FIH) clinical study of the Amplifi™ Vein Dilation System were presented at the 2021 VEITH Symposium by Surendra Shenoy, MD-PhD, an Associate Professor of Surgery at the Washington University School of Medicine at Barnes-Jewish Hospital in St. Louis,

Read More

Prairie Village, KS – October 7, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced that preliminary clinical results from its first-in-human study of the Amplifi™ Vein Dilation System were presented at the 2021 Vascular Interventional Advances (VIVA) conference. Data were presented during a Late-Breaking Clinical Trial session by Surendra Shenoy, MD-PhD, an Associate Professor of

Read More

Read More

Prairie Village, KS – September 16, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Joe McConnell as Vice President of Business Operations and Finance and Irina Galkina as Controller. After graduating summa cum laude from Princeton University, McConnell joined the US Army as an officer and served with the 3rd Infantry Division

Read More

Prairie Village, KS – August 31, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Wendy Sawyer as Senior Vice President of Operations and Quality and Mimi Fitterer as Senior Director of Technology. Sawyer joins Artio with over 30 years of experience in medical device operations, manufacturing, and product development. Most recently, she

Read More

Presentation showcases immediate, complete, and lasting peripheral artery occlusion achieved in a study with company’s new embolization technology Prairie Village, KS – August 10, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the presentation of data highlighting the performance of its Solus Gold Embolization Device during a session on new embolization devices at the 2021 Global

Read More

Novel vein dilation system aims to improve vascular access for hemodialysis patients Prairie Village, KS – July 29, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, announced today it has completed enrollment in its first-in-human study evaluating the company’s Amplifi™ Vein Dilation System. Five patients were treated by Dr. Adrian Ebner, the Head of the Cardiovascular Department

Read More

Company expands leadership team ahead of first US product launch Prairie Village, KS – July 14, 2021 – Artio Medical, Inc., a medical device company developing innovative products for the peripheral vascular, neurovascular, and structural heart markets, today announced the hiring of Erdie De Peralta as Vice President of Clinical and Regulatory Affairs and Delane Dale as Senior Director of Quality Assurance. De Peralta and Dale have joined Artio as

Read More

Read More